Compare ALEMBIC PHARMA with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA NOVARTIS ALEMBIC PHARMA/
NOVARTIS
 
P/E (TTM) x 16.0 2,030.6 0.8% View Chart
P/BV x 6.4 27.0 23.6% View Chart
Dividend Yield % 0.6 1.6 36.6%  

Financials

 ALEMBIC PHARMA   NOVARTIS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
NOVARTIS
Mar-19
ALEMBIC PHARMA/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs664980 67.8%   
Low Rs412600 68.7%   
Sales per share (Unadj.) Rs208.7198.7 105.0%  
Earnings per share (Unadj.) Rs31.021.0 147.8%  
Cash flow per share (Unadj.) Rs37.122.3 166.7%  
Dividends per share (Unadj.) Rs5.5010.00 55.0%  
Dividend yield (eoy) %1.01.3 80.7%  
Book value per share (Unadj.) Rs144.2307.5 46.9%  
Shares outstanding (eoy) m188.5224.69 763.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.64.0 64.9%   
Avg P/E ratio x17.437.7 46.1%  
P/CF ratio (eoy) x14.535.5 40.9%  
Price / Book Value ratio x3.72.6 145.2%  
Dividend payout %17.747.7 37.2%   
Avg Mkt Cap Rs m101,46119,508 520.1%   
No. of employees `000NA0.6 0.0%   
Total wages/salary Rs m7,4671,171 637.6%   
Avg. sales/employee Rs ThNM8,445.4-  
Avg. wages/employee Rs ThNM2,015.7-  
Avg. net profit/employee Rs ThNM891.0-  
INCOME DATA
Net Sales Rs m39,3474,907 801.9%  
Other income Rs m94783 12.0%   
Total revenues Rs m39,4415,689 693.2%   
Gross profit Rs m8,736123 7,113.8%  
Depreciation Rs m1,15232 3,623.6%   
Interest Rs m18416 1,157.9%   
Profit before tax Rs m7,493858 873.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568340 461.0%   
Profit after tax Rs m5,844518 1,128.8%  
Gross profit margin %22.22.5 887.1%  
Effective tax rate %20.939.6 52.8%   
Net profit margin %14.910.6 140.8%  
BALANCE SHEET DATA
Current assets Rs m19,5778,055 243.1%   
Current liabilities Rs m14,8961,850 805.2%   
Net working cap to sales %11.9126.4 9.4%  
Current ratio x1.34.4 30.2%  
Inventory Days Days9045 199.3%  
Debtors Days Days4534 133.7%  
Net fixed assets Rs m27,097150 18,088.7%   
Share capital Rs m377123 305.5%   
"Free" reserves Rs m26,8117,469 359.0%   
Net worth Rs m27,1887,592 358.1%   
Long term debt Rs m4,9930-   
Total assets Rs m47,7789,824 486.3%  
Interest coverage x41.754.9 75.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.5 164.9%   
Return on assets %12.65.4 232.3%  
Return on equity %21.56.8 315.2%  
Return on capital %23.611.5 205.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45358 33,772.0%   
Fx outflow Rs m6,0651,326 457.3%   
Net fx Rs m13,388-1,269 -1,055.2%   
CASH FLOW
From Operations Rs m8,120-1,943 -417.9%  
From Investments Rs m-7,5562,742 -275.5%  
From Financial Activity Rs m590-298 -198.0%  
Net Cashflow Rs m1,153501 230.1%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.9 2.0 145.0%  
FIIs % 9.1 1.6 568.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 21.5 64.7%  
Shareholders   49,328 41,647 118.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  STERLING BIOTECH  JUBILANT PHARMOVA   

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Mar 5, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - SUVEN LIFE SCIENCES COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS